New anesthesia method aims to cut opioid use in elderly spine surgery patients
NCT ID NCT07588802
First seen Jun 27, 2026 · Last updated Sep 09, 2026 · Updated 2 times
Summary
This study tests a special anesthesia method that uses fewer opioids during spine surgery in people aged 65 and older. The goal is to see if it lowers pain and the need for strong painkillers after surgery. Half the participants will get this opioid-sparing anesthesia, and the other half will get the usual anesthesia. Researchers will track pain levels and opioid use for three days after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
About 120 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
May 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
65 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Aged ≥ 65 years * Undergoing multilevel level (≥2 levels) spine surgery under general anesthesia * Able to provide written informed consent Exclusion Criteria: * Diagnosed with severe cognitive impairment or psychiatric disorders that impair participation or communication * Pregnant or breastfeeding * Patients with contraindications to any of the medications in the study protocol (unstable angina, recent myocardial infarction, cerebral or aortic aneurysms, increased intracranial pressure, increased intraocular pressure, psychosis or schizophrenia, pheochromocytoma, epilepsy, second- or third-degree atrioventricular block, bradycardia (heart rate \< 50bpm), liver failure, hypotension (systolic BP \<80 mmHg)) * Drug or alcohol abuse * Refuse to participate
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Opoid managment are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug tested to curb pain after liver surgery
- Two simple tweaks may cut pain after appendix surgery
- Nerve blocks put to the test for chest tube pain
- Hyaluronic acid gel vs standard paste: which calms infected root canals better?
- Cooling spray takes aim at the sting of an IV
- Heat may boost numbing power of lidocaine for eye shots